Give the most
gift you can
For the one who wants to start their DNA journey with a deep dive into their ancestry.
Give them a comprehensive portrait of where in the world their DNA is from.
- 80+ personalized reports
- Ancestry percentages (to the 0.1%)
- 2750+ geographic regions
- Health upgrade available
- †The most comprehensive ancestry breakdown on the market
Health plus Ancestry Service
For the one who wants a snapshot of their current health insights.
Give them essential DNA insights into their health like type 2 diabetes and muscle composition.
- Includes everything from our Ancestry kit
- Plus 65+ health reports and features
- Includes FDA-authorized reports
For the one who’s never done being healthy.
Give them an annual membership that includes access to new premium reports and features throughout the year.
- Includes everything from our Health plus Ancestry kit
- PLUS access to exclusive reports that help them learn about their heart health, how they process certain medications**Learn about Considerations and Limitations for Pharmacogenetics Reports, migraine, and more
- Just Added Our Health TracksSM lets them see how making healthy choices each day can greatly impact their health over time.
- Just Added Health Action Plan gives them personalized and ongoing recommendations based on genetic and non-genetic data.
- Enhanced ancestry features
- First year membership included (renews at $69peryr) and valid payment method required at kit registration
For the one who wants our most advanced health membership yet.
Give them a membership that focuses ongoing prevention and early detection.
- Includes everything in 23andMeplus Premium
- Exome sequencing and interpretations of 100+ genes linked to 55+ conditions
- Biannual blood testing with analysis of 55+ blood biomarkers.
- Genetics-based clinical care, including a virtual clinical consultation and unlimited messaging
- Valid payment method required at kit registration
- 23andMeplus Total Health is not available to residents of HI, NJ, NY, OK, RI and US territories, and not available to existing 23andMe customers until Spring 2024
Compare all gifts
Remember, you can always upgrade without having to spit again.
|Health plus Ancestry Service
Genotyping examines DNA variants at certain pre-identified positions in the genome. The specific variants we look at generally provide coverage of commonly known variations across the entire genome.
Exome Sequencing Reports
Exome sequencing is an advanced genetic testing technique that focuses on decoding the exome of an individual's genome. The exome represents the protein-coding regions of genes, which make up only about 2% of the entire genome but contain the majority of genetic variants associated with disease risk.
|Ancestry and Trait Reports
|DNA Relative Finder and Family Tree (Opt in)
|Health Predisposition reports*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks
Learn how your genetics can influence your chances of developing certain health conditions.
|Carrier Status reports*Learn about Considerations and Limitations for Health Predispositions Reports, Carrier Status Reports and Genetic Health Risks
If you are starting a family, find out if you are a carrier for certain inherited conditions.
Learn how your genes play a role in your well-being and lifestyle choices.
|Family Health History Tree
Opt in to easily input, track and download your family health history to share with your healthcare provider.
|Pharmacogenetics reports**Learn about Considerations and Limitations for Pharmacogenetics Reports
Discover how your DNA may impact how your body processes certain medications with three new Pharmacogenetics reports.
|Enhanced ancestry features
Get advanced filtering for DNA Relative Finder and access up to 5000 more DNA relatives.
|Ongoing new reports
Get access to new premium reports and features throughout the year.
See how making healthy choices each day can greatly impact your health over time
Health Action Plan
Personalized and ongoing recommendations based on genetic and non-genetic data.
Eligible participants may order in-person blood testing initiated by a clinician and get results in the 23andMe app.
Genetics-based clinical care
Access to clinicians with training in genetics. Includes unlimited direct messaging, plus a dedicated virtual consultation annually.
Frequently Asked Questions
Standard, Expedited, and Express shipping methods are available. Standard and Expedited orders are shipped through USPS. Express orders are shipped through FedEx Standard Overnight. Here are expected delivery timeframes from the date of shipment:
- Standard: delivery within 3-6 business days
- Expedited: delivery within 2-3 business days
- Express: delivery within 1-2 business days
Reports will be available through a secure, online account at 23andme.com in approximately 3-4 weeks.
Stay in the know.
Keep up-to-date with new discoveries and exclusive promotions on our DNA testing kits and services.
*The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of 44 variants in the BRCA1 and BRCA2 genes. The report describes if a person's genetic result is associated with an increased risk of developing breast cancer and ovarian cancer and may be associated with an increased risk for prostate cancer, pancreatic cancer, and potentially other cancers. The variants included in this report do not represent the majority of the BRCA1/BRCA2 variants in people of most ethnicities. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. This report is for over-the-counter use by adults over the age of 18, and provides genetic information to inform discussions with a healthcare professional. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit 23andme.com/test-info/
**23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene, 2 variants in the DPYD gene and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. Our SLCO1B1 Pharmacogenetics report provides certain information about variants associated with the processing of some therapeutics and provides interpretive drug information regarding the potential effect of simvastatin therapy. Our DPYD Pharmacogenetics report does not describe the association between detected variants and any specific therapeutic. Results for DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. For important information and limitations regarding Pharmacogenetic reports, visit 23andme.com/test-info/pharmacogenetics/